Stock Events

Stock Events

Integra Lifesciences 

$11.91
13
-$0.41-3.37% 20:00 Today
+$0.00+0%20:00After hours

Statistics

Day High
12.4
Day Low
11.82
52W High
20.49
52W Low
8.7
Volume
1,212,688
Avg. Volume
961,487
Mkt Cap
926.27M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Oct 21Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Q3 2026
0.4
0.59
0.78
0.97
Expected EPS
0.557413
Actual EPS
0.59

Financials

-31.58%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.64BRevenue
-516.47MNet Income

Analyst Ratings

$16.43Average Price Target
The highest estimate is ⁦22.00⁩.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
86%
Sell
14%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IART. It's not an investment recommendation.
Altria Group
5
MO
Biomarin Pharmaceutical
5
BMRN
Microsoft
4
MSFT
Realty Income
4
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation competes directly with Integra Lifesciences in the medical technology and surgical instruments sector, offering similar products for neurosurgery and orthopedics.
Medtronic
MDT
Mkt Cap110.49B
Medtronic plc offers a wide range of medical devices that compete with Integra's offerings, especially in the neurosurgery and spinal products market.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical products and wound care, overlapping with Integra's product lines.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings, Inc. competes in the orthopedic and neurosurgery sectors, offering products that directly compete with Integra's surgical instruments and implants.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific Corporation offers products in the neuromodulation and neurovascular sectors, competing with Integra Lifesciences' neurosurgical product lines.
Globus Medical
GMED
Mkt Cap10.15B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic surgery products, competing with Integra's offerings.
Integra Lifesciences
IART
Mkt Cap986.16M
Integra Lifesciences competes with itself through its diverse range of products, constantly innovating and expanding its portfolio to stay competitive in the market.
Alphatec
ATEC
Mkt Cap1.55B
Alphatec Holdings, Inc. is a provider of spinal surgery solutions, competing in the same space as Integra Lifesciences with its focus on innovative spinal products and technologies.

About

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Show More
CEO
Stuart Essig
Employees
4427
Country
United States
ISIN
US4579852082
WKN
000897013

Listings

STU
DE
IL3.STU
MU
DE
IL3.MU
BOATS
BOATS
IART.BOATS
F
DE
IL3.F

0 Comments

Share your thoughts

FAQs

What is Integra Lifesciences stock price today?▼
The current price of IART is $11.91 USD — it has decreased by -3.37% in the past 24 hours. Watch Integra Lifesciences stock price performance more closely on the chart.
What is Integra Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Integra Lifesciences stocks are traded under the ticker IART.
Is Integra Lifesciences stock price growing?▼
IART stock has fallen by -9.84% compared to the previous week, the month change is a -23.31% fall, over the last year Integra Lifesciences has showed a -25% decrease.
What is Integra Lifesciences market cap?▼
Today Integra Lifesciences has the market capitalization of 926.27M
When is the next Integra Lifesciences earnings date?▼
Integra Lifesciences is going to release the next earnings report on March 3, 2027.
What were Integra Lifesciences earnings last quarter?▼
IART earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.56 USD resulting in a +5.85% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Integra Lifesciences revenue for the last year?▼
Integra Lifesciences revenue for the last year amounts to 1.64B USD.
What is Integra Lifesciences net income for the last year?▼
IART net income for the last year is -516.47M USD.
How many employees does Integra Lifesciences have?▼
As of October 23, 2026, the company has 4,427 employees.
In which sector is Integra Lifesciences located?▼
Integra Lifesciences operates in the Health & Wellness sector.
When did Integra Lifesciences complete a stock split?▼
The last stock split for Integra Lifesciences was on January 4, 2017 with a ratio of 2:1.
Where is Integra Lifesciences headquartered?▼
Integra Lifesciences is headquartered in PRINCETON, United States.